Ra Capital Management, L.P. Legend Biotech Corp Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Legend Biotech Corp stock. As of the latest transaction made, Ra Capital Management, L.P. holds 7,506,934 shares of LEGN stock, worth $325 Million. This represents 5.1% of its overall portfolio holdings.
Number of Shares
7,506,934
Previous 7,506,934
-0.0%
Holding current value
$325 Million
Previous $332 Million
10.02%
% of portfolio
5.1%
Previous 5.01%
Shares
11 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$484 Million0.06% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$287 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$248 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$218 Million1.16% of portfolio
-
Invesco Ltd. Atlanta, GA2.29MShares$99.1 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.25B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...